http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2770988-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78a80a8ab31cfe89047694762b8b0138
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
filingDate 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df44b2a9b291ad6c9499d0c2b8814b37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc524594fd6a66fd33cb1da8fd4d2d3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d68f7550a14a4b684e3f4763b0045b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a6f1d4a52707984cb8acd6dc56070f
publicationDate 2014-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2770988-A1
titleOfInvention New therapy for transthyretin-associated amyloidosis
abstract It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
priorityDate 2011-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128165060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4675622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4659569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127495684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12443252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226498328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128318411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127880219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129796310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129402018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128363854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128601362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4659568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127517581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246

Total number of triples: 81.